KKR III GP LLC, 10% Owner at Jazz Pharmaceuticals plc (JAZZ), sold 3,750,000 shares at $58.28 ($218.6M) on 2013-03-08, disclosed to the SEC on 2013-03-12.
Open-market sale of $218.6M JAZZ by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.28 | 15,865 | $925K | 0.4% |
| 2 | $58.28 | 3,734,135 | $217.6M | 99.6% |
| Total | $58.28 avg | 3,750,000 | $218.6M | 100% |
| Filing → |
| USFD | SELL | 2017-05-19 | $1.2B | — | Filing → |
| GDDY | SELL | 2016-08-08 | $144.0M | — | Filing → |
| HCA | SELL | 2014-05-28 | $761.5M | — | Filing → |